CD100在正常皮肤、急性创面及慢性创面中的表达研究(4)
[12]Binmadi NO，Proia P，Zhou H，et al.Rho-mediated activation of PI(4)P5K and lipid second messengers is necessary for promotion of angiogenesis by Semaphorin 4D[J].Angiogenesis，2011，14(3)：309-319.
[13]Basile JR，Barac A，Zhu T，et al.Class Ⅳsemaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B[J].Cancer Res，2004，64(15)：5212-5224.
[14]Wannemacher KM，Wang L，Zhu L，et al.The role of semaphorins and their receptors in platelets： Lessons learned from neuronal and immune synapses[J].Platelets，2011，22(6)：461-465.
[15]Zhu L，Bergmeier W，Wu J，et al.Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury[J].Proc Natl Acad Sci U S A，2007，104(5)：1621-1626.
[16]Witherden DA，Watanabe M，Garijo O，et al.The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal gammadelta T cell function[J].Immunity，2012，37(2)：314-325.
[17]Chodaczek G，Papanna V，Zal MA，et al.Body-barrier surveillance by epidermal gammadelta TCRs[J].Nat Immunol，2012，13(3)：272-282.
[18]Motani K，Kosako H.Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D[J].J Biol Chem，2018，293(20)：7717-7726.
[19]Basile JR，Holmbeck K，Bugge TH，et al.MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D[J].J Biol Chem，2007，282(9)：6899-6905.
[20]Chapoval SP，Vadasz Z，Chapoval AI，et al.Semaphorins 4A and 4D in chronic inflammatory diseases [J].Inflamm Res，2017，66(2)：111-117.
[21]Wang F，Liu B，Yu Z，et al.Effects of CD100 promote wound healing in diabetic mice [J].J Mol Histol，2018，49(3)：277-287.
[收稿日期]2018-06-12 [修回日期]2018-07-13
編辑/朱婉蓉, 百拇医药(刘蓓 王芳 陈琳 余州 宋雅娟 王彤 苏映军)
[13]Basile JR，Barac A，Zhu T，et al.Class Ⅳsemaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B[J].Cancer Res，2004，64(15)：5212-5224.
[14]Wannemacher KM，Wang L，Zhu L，et al.The role of semaphorins and their receptors in platelets： Lessons learned from neuronal and immune synapses[J].Platelets，2011，22(6)：461-465.
[15]Zhu L，Bergmeier W，Wu J，et al.Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury[J].Proc Natl Acad Sci U S A，2007，104(5)：1621-1626.
[16]Witherden DA，Watanabe M，Garijo O，et al.The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal gammadelta T cell function[J].Immunity，2012，37(2)：314-325.
[17]Chodaczek G，Papanna V，Zal MA，et al.Body-barrier surveillance by epidermal gammadelta TCRs[J].Nat Immunol，2012，13(3)：272-282.
[18]Motani K，Kosako H.Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D[J].J Biol Chem，2018，293(20)：7717-7726.
[19]Basile JR，Holmbeck K，Bugge TH，et al.MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D[J].J Biol Chem，2007，282(9)：6899-6905.
[20]Chapoval SP，Vadasz Z，Chapoval AI，et al.Semaphorins 4A and 4D in chronic inflammatory diseases [J].Inflamm Res，2017，66(2)：111-117.
[21]Wang F，Liu B，Yu Z，et al.Effects of CD100 promote wound healing in diabetic mice [J].J Mol Histol，2018，49(3)：277-287.
[收稿日期]2018-06-12 [修回日期]2018-07-13
編辑/朱婉蓉, 百拇医药(刘蓓 王芳 陈琳 余州 宋雅娟 王彤 苏映军)